Development and Characterization of Neutralizing Antibodies Against Zaire Ebolavirus Glycoprotein and Protein 40.
Yu, Dong-Shan; Weng, Tian-Hao; Shen, Ling; Wu, Xiao-Xin; Hu, Chen-Yu; Wang, Frederick X C; Wu, Zhi-Gang; Wu, Hai-Bo; Wu, Nan-Ping; Li, Lan-Juan; Yao, Hangping.
Cell Physiol Biochem
; 50(3): 1055-1067, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-30355918
Structures of protective antibodies reveal sites of vulnerability on Ebola virus.
Membrane pore formation and ion selectivity of the Ebola virus delta peptide.
The amino terminal subdomain of glycoprotein Gc of Schmallenberg virus: disulfide bonding and structural determinants of neutralization.
Antibodies from a Human Survivor Define Sites of Vulnerability for Broad Protection against Ebolaviruses.
Protein Interaction Mapping Identifies RBBP6 as a Negative Regulator of Ebola Virus Replication.
Ebola virus proteins NP, VP35, and VP24 are essential and sufficient to mediate nucleocapsid transport.
Comparative Analysis of Host Cell Entry of Ebola Virus From Sierra Leone, 2014, and Zaire, 1976.
Identification of a conserved neutralizing epitope in the G-protein of Chandipura virus.
Design and evaluation of bi- and trispecific antibodies targeting multiple filovirus glycoproteins.
Resonance-Frequency Modulation for Rapid, Point-of-Care Ebola-Glycoprotein Diagnosis with a Graphene-Based Field-Effect Biotransistor.